Ingevity Corp Files 8-K on Dec 1, 2025

TL;DR

Ingevity filed an 8-K on 12/1/25, check for Reg FD and financial updates.

AI Summary

Ingevity Corporation filed an 8-K on December 1, 2025, reporting on matters including Regulation FD Disclosure and Financial Statements and Exhibits. The filing details the company's principal executive offices located at 4920 O'Hear Avenue, Suite 400, North Charleston, South Carolina, 29405.

Why It Matters

This 8-K filing provides official updates and disclosures from Ingevity Corp to the SEC, which are important for investors to stay informed about the company's regulatory and financial reporting.

Risk Assessment

Risk Level: low — This filing is a routine 8-K for disclosures and financial statements, not indicating immediate significant operational or financial risk.

Key Players & Entities

• Ingevity Corporation (company) — Registrant
• 4920 O'Hear Avenue Suite 400 North Charleston South Carolina 29405 (location) — Principal executive offices

FAQ

Key Financial Figures

• $0.01 — ange on which registered Common Stock ($0.01 par value) NGVT New York Stock Exchange

Filing Documents

• ngvt-20251201.htm (8-K) — 31KB
• ex991discops.htm (EX-99.1) — 1587KB
• ngvt-20251201_g1.jpg (GRAPHIC) — 143KB
• 0001653477-25-000133.txt ( ) — 2093KB
• ngvt-20251201.xsd (EX-101.SCH) — 2KB
• ngvt-20251201_lab.xml (EX-101.LAB) — 21KB
• ngvt-20251201_pre.xml (EX-101.PRE) — 12KB
• ngvt-20251201_htm.xml (XML) — 3KB

01. REGULATION FD DISCLOSURE

ITEM 7.01. REGULATION FD DISCLOSURE On September 3, 2025, Ingevity Corporation, a Delaware corporation ("Ingevity", "the Company") entered into an Asset Purchase Agreement (the "Purchase Agreement") with Mainstream Pine Products, LLC, a Delaware limited liability company ("Purchaser"), pursuant to which Purchaser will purchase substantially all of the assets and assume and acquire certain of the rights and liabilities of Ingevity or its applicable affiliates that relate to or are used in connection with (a) Ingevity's industrial specialties product line (other than Ingevity's lignin dispersant and alternative fatty acid based products, road technologies product line and other businesses and products more fully described in the Purchase Agreement) and (b) Ingevity's North Charleston, South Carolina crude tall oil refinery (the "CTO Refinery") and Ingevity's and its affiliates' operations thereof (collectively, the "Divestiture"). The Divestiture is expected to close by early 2026. Ingevity previously disclosed the Divestiture and the Asset Purchase Agreement (the "Purchase Agreement") in a Current Report on Form 8-K filed by Ingevity with the Securities and Exchange Commission (the "SEC") on September 3, 2025 (the "Previous Form 8-K"). The foregoing description of the Purchase Agreement and the acquisition does not purport to be complete and is subject to, and qualified in its entirety by, the full text of the Purchase Agreement filed as Exhibit 2.1 to the Previous Form 8-K, which is incorporated herein by reference. In connection with the transaction, the Company determined that the industrial specialties product line and CTO Refinery included within the Divestiture met the criteria to be classified as held for sale and that the sale represents a strategic shift that will have a major effect on Ingevity's operations and results. Accordingly, for all periods presented, the results of operations of the industrial specialties product line and CTO Refinery, collectiv

01. FINANCIAL STATEMENTS AND EXHIBITS

ITEM 9.01. FINANCIAL STATEMENTS AND EXHIBITS (d) Exhibits. Exhibit No. Description of Exhibit 2.1 Asset Purchase Agreement, dated September 3, 2025, by and between Ingevity Corporation and Mainstream Pine Products, LLC (incorporated by reference to Exhibit 2.1 to the Company's Current Report on Form 8-K, as filed with the U.S. Securities and Exchange Commission on September 4, 2025)* 99.1 Recast Condensed Consolidated Statement of Operations, Historical Segment Information and certain Non-GAAP Financial Measures Reflecting the Industrial Specialties product line and CTO Refinery as Discontinued Operations (Unaudited) 104 Cover Page Interactive Data File (embedded within the Inline XBRL document) * Incorporated by reference.

SIGNATURES

SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. INGEVITY CORPORATION (Registrant) By: /S/ MARY DEAN HALL Mary Dean Hall Executive Vice President and Chief Financial Officer Date: December 1, 2025